To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FTSJ1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
533 supporting clones for gene FTSJ1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA050794   .a 1 to 571 2 to 572   tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
CR595180 T cells (Jurkat cell line) .a 31 to 1411 1 to 1381 exact tiling clone,   1381/1381
(100 %)
0 diff
(100 %id)
BX447680 T cells (Jurkat cell line) .a 31 to 721 1 to 691   fully sequenced,   691/691
(100 %)
6 diff
(99.2 %id)
W30749 senescent fibroblast .a 401 to 781 1 to 387       387/428
(90 %)
16 diff
(96.3 %id)
BX447679 T cells (Jurkat cell line) .a 660 to 1411 749 to 1   fully sequenced,   749/749
(100 %)
7 diff
(99.1 %id)
AI393192 B-cell, chronic lymphotic leukemia .a 798 to 1443 657 to 12   AAA   646/664
(97 %)
11 diff
(98.4 %id)
AI653963 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 890 to 1444 580 to 27   AAA   554/554
(100 %)
20 diff
(96.4 %id)
AI073713 senescent fibroblast .a 900 to 1446 548 to 3       546/608
(89 %)
5 diff
(99.2 %id)
CA423934 cell lines, Chondrosarcoma .a 972 to 1443 490 to 19   AAA   472/472
(100 %)
0 diff
(100 %id)
AA526084 normal prostate, Prostate .a 987 to 1441 477 to 24   AAA   454/533
(85 %)
8 diff
(98.5 %id)
N94524 senescent fibroblast .a 994 to 1446 454 to 3       452/454
(99 %)
0 diff
(100 %id)
BQ447312 Knee, Osteoarthritic Cartilage .a 1291 to 1934 659 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 643/643
(100 %)
2 diff
(99.7 %id)
AA487493   .a 1815 to 2190 376 to 1   tiling clone,   376/376
(100 %)
1 diff
(99.8 %id)
CN270603 embryonic stem cells, DMSO-treated H9 cellline .a 2105 to 2427 1 to 324   tiling clone,   324/324
(100 %)
6 diff
(98.2 %id)
R23444 whole brain .b 1 to 427 1 to 429   tiling clone,   429/523
(82 %)
25 diff
(95.3 %id)
AA158316 Pancreas .b 25 to 402 1 to 381       381/385
(98 %)
13 diff
(96.7 %id)
CR616099 T cells (Jurkat cell line) Cot10-normalized .b 30 to 1349 1 to 1320 exact tiling clone,   1320/1320
(100 %)
0 diff
(100 %id)
AL558131 T cells from T cell leukemia .b 30 to 899 1 to 869   fully sequenced,   869/869
(100 %)
3 diff
(99.7 %id)
BG754886 B-cells, primary B-cells from tonsils (cell line) .b 673 to 1405 1 to 729   AAA   729/729
(100 %)
3 diff
(99.6 %id)
BQ675404 epidermoid carcinoma, cell line, salivary gland .b 702 to 1405 1 to 703   AAA   703/703
(100 %)
1 diff
(99.9 %id)
AL580036 T cells from T cell leukemia .b 838 to 1349 516 to 1   fully sequenced,   516/516
(100 %)
7 diff
(98.7 %id)
AA158317 Pancreas .b 1025 to 1408 387 to 3   tiling clone,   385/387
(99 %)
0 diff
(100 %id)
AW080179 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 1046 to 1405 382 to 22   AAA   361/403
(89 %)
17 diff
(95.8 %id)
AA837891 epithelium (cell line), Prostate .b 1051 to 1406 356 to 1       356/358
(99 %)
3 diff
(99.2 %id)
AW069434 bone marrow stroma .b 1079 to 1405 358 to 32   AAA   327/327
(100 %)
1 diff
(99.7 %id)
H05981 whole brain .b 1097 to 1405 333 to 23   AAA   311/311
(100 %)
3 diff
(99.1 %id)
AW072116 anaplastic oligodendroglioma, brain .b 1122 to 1408 292 to 6       287/292
(98 %)
0 diff
(100 %id)
AA828821 ovary .b 1133 to 1405 1 to 273   AAA   273/273
(100 %)
5 diff
(98.2 %id)
R44226 whole brain .b 1136 to 1406 297 to 24   AAA   274/274
(100 %)
5 diff
(98.2 %id)
BF590463 colon, colon tumor, RER+ .b 1174 to 1408 239 to 5       235/239
(98 %)
0 diff
(100 %id)
DB049661 testis .c 1 to 565 2 to 566   tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
DA959748 Spleen .c 119 to 683 2 to 572   capped   571/571
(100 %)
8 diff
(98.6 %id)
DA697537   .c 147 to 630 2 to 487   capped   486/486
(100 %)
2 diff
(99.6 %id)
DA728892   .c 164 to 846 2 to 684   capped   683/683
(100 %)
2 diff
(99.8 %id)
DA997898   .c 164 to 696 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
DA352431 substantia nigra .c 236 to 808 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA368160 subthalamic nucleus .c 237 to 802 2 to 576   capped   575/575
(100 %)
12 diff
(98.0 %id)
DA753910   .c 239 to 804 2 to 567   capped   566/566
(100 %)
4 diff
(99.3 %id)
DA050832   .c 245 to 803 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA684689   .c 245 to 777 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
NM_012280.2   .c 258 to 2208 1 to 1951 exact RefSeq,   1951/1951
(100 %)
0 diff
(100 %id)
DB003417 breast, tumor tissue .c 259 to 799 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
DA297189 hippocampus .c 268 to 770 2 to 506   capped   505/505
(100 %)
4 diff
(99.3 %id)
DA566453 heart .c 268 to 829 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA687867   .c 268 to 696 2 to 430   capped   429/429
(100 %)
0 diff
(100 %id)
DA879186 Prostate .c 268 to 830 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB025149 testis .c 268 to 816 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA632660 Kidney .c 269 to 832 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DB456334 testis .c 273 to 726 1 to 454       454/454
(100 %)
6 diff
(98.7 %id)
DA048844   .c 274 to 561 2 to 289   capped   288/288
(100 %)
0 diff
(100 %id)
DA062491 cerebellum .c 274 to 841 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA276153 corpus callosum .c 274 to 838 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA466769 cord Blood .c 274 to 735 2 to 463   capped   462/463
(99 %)
5 diff
(99.0 %id)
DA685875   .c 274 to 804 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
DA818963   .c 274 to 831 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DB013660 esophageal, tumor tissue .c 274 to 843 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DB255777 uterus .c 274 to 828 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DN996496 breast cancer, Mammary gland (cancer tissue) .c 277 to 1040 1 to 764       764/768
(99 %)
8 diff
(99.0 %id)
DB442725 testis .c 280 to 735 1 to 456       456/456
(100 %)
0 diff
(100 %id)
AJ005892   .c 281 to 2147 1 to 1867 exact     1867/1867
(100 %)
0 diff
(100 %id)
DA047036   .c 288 to 1019 2 to 732   capped   731/735
(99 %)
8 diff
(99.0 %id)
DA201122 brain .c 288 to 877 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DA750609   .c 288 to 515 2 to 229   capped   228/228
(100 %)
0 diff
(100 %id)
DA943179 Spleen .c 288 to 865 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB013740 esophageal, tumor tissue .c 288 to 853 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BP872746 embryonal kidney .c 289 to 860 1 to 572       572/582
(98 %)
14 diff
(97.6 %id)
BP873178 embryonal kidney .c 289 to 862 1 to 574       574/582
(98 %)
3 diff
(99.5 %id)
BJ994267 hepatoblastoma .c 289 to 772 1 to 484       484/484
(100 %)
0 diff
(100 %id)
BI115976 lung, small cell carcinoma .c 289 to 1152 1 to 855       859/926
(92 %)
18 diff
(98.1 %id)
DA050893   .c 290 to 855 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA073225 cerebellum .c 290 to 844 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BG327733 Kidney, renal cell adenocarcinoma .c 290 to 1013 1 to 723       723/725
(99 %)
10 diff
(98.7 %id)
DA656314   .c 290 to 851 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA680335   .c 290 to 843 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA683306   .c 290 to 782 2 to 494   capped   493/493
(100 %)
1 diff
(99.8 %id)
BI259467 cervical carcinoma cell line, cervix .c 291 to 936 1 to 645       645/645
(100 %)
6 diff
(99.1 %id)
BM152203 leukopheresis .c 291 to 759 1 to 469       469/469
(100 %)
5 diff
(99.0 %id)
DB485472 hypothalamus .c 292 to 611 1 to 322       322/322
(100 %)
36 diff
(88.9 %id)
DB504308 hypothalamus .c 292 to 769 1 to 480       480/480
(100 %)
5 diff
(99.0 %id)
DA612258   .c 292 to 839 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DA612972   .c 293 to 876 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
DA679840   .c 293 to 778 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DA684958   .c 293 to 838 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA688040   .c 293 to 806 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DA715179   .c 293 to 847 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA935690 Spleen .c 293 to 885 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA948570 Spleen .c 293 to 770 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA964797 stomach .c 293 to 849 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
CB113738 Liver .c 294 to 808 1 to 516       516/516
(100 %)
4 diff
(99.3 %id)
DA638956 Liver .c 294 to 778 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
DA006925   .c 295 to 865 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA042227 bladder .c 295 to 861 2 to 568   capped   567/568
(99 %)
1 diff
(99.9 %id)
DA063955 cerebellum .c 295 to 855 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA158167 amygdala .c 295 to 855 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA268354 caudate nucleus .c 295 to 830 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA279935 corpus callosum .c 295 to 859 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
CR595767 Neuroblastoma Cot 25-normalized .c 295 to 2178 1 to 1884 exact tiling clone,   1884/1884
(100 %)
0 diff
(100 %id)
AL524015 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 295 to 1241 1 to 945   fully sequenced,   945/945
(100 %)
10 diff
(99.0 %id)
DA487180 brain .c 295 to 865 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA561748 heart .c 295 to 772 2 to 479   capped   478/491
(97 %)
1 diff
(99.8 %id)
DA563032 heart .c 295 to 862 2 to 570   capped   569/573
(99 %)
3 diff
(99.5 %id)
DA597036   .c 295 to 840 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DA616328   .c 295 to 874 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
TI_57166660   .c 295 to 1121 28 to 864       837/865
(96 %)
19 diff
(97.9 %id)
DA686965   .c 295 to 839 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA690400   .c 295 to 872 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA792681 brain .c 295 to 861 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA969191 stomach .c 295 to 849 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA970239 stomach .c 295 to 848 12 to 565   capped   554/554
(100 %)
1 diff
(99.9 %id)
BP871811 embryonal kidney .c 296 to 862 1 to 567       567/583
(97 %)
7 diff
(98.8 %id)
BP872787 embryonal kidney .c 296 to 875 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BQ430757 embryonal carcinoma, cell line, testis .c 296 to 1102 1 to 815       815/860
(94 %)
11 diff
(98.8 %id)
DA086782 cerebellum .c 297 to 854 2 to 563   capped   562/562
(100 %)
5 diff
(99.2 %id)
DA380214 thalamus .c 297 to 845 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BG705870 brain, hypothalamus .c 297 to 973 1 to 698       636/698
(91 %)
25 diff
(96.5 %id)
CB594860 Blood, promyelocytic leukemia .c 297 to 1068 1 to 782       782/919
(85 %)
22 diff
(97.7 %id)
DA694067   .c 297 to 854 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA716650   .c 297 to 810 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DA749478   .c 297 to 861 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA892858 skeletal muscle .c 297 to 995 2 to 697   capped   696/710
(98 %)
11 diff
(98.5 %id)
DA925686 small intestine .c 297 to 869 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA705736   .c 298 to 820 2 to 524   capped   523/523
(100 %)
1 diff
(99.9 %id)
DA751727   .c 299 to 719 145 to 565   capped   421/564
(74 %)
6 diff
(99.0 %id)
DB111274 thymus .c 299 to 820 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
DA007962   .c 300 to 850 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA419957 cord Blood .c 300 to 876 2 to 578   capped   577/579
(99 %)
3 diff
(99.5 %id)
DA563786 heart .c 300 to 813 2 to 517   capped   516/516
(100 %)
3 diff
(99.5 %id)
BP272559   .c 300 to 702 1 to 403       403/584
(69 %)
12 diff
(98.0 %id)
AU099831   .c 300 to 581 19 to 300       282/300
(94 %)
7 diff
(97.7 %id)
DA692887   .c 300 to 771 2 to 473   capped   472/472
(100 %)
1 diff
(99.8 %id)
DB113438 thymus .c 300 to 891 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DB120236 thymus .c 300 to 810 2 to 512   capped   511/511
(100 %)
0 diff
(100 %id)
DB248413 uterus .c 300 to 930 2 to 632   capped   631/631
(100 %)
0 diff
(100 %id)
DA017221 adrenal gland .c 301 to 864 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA032741   .c 301 to 534 2 to 235   capped   234/234
(100 %)
0 diff
(100 %id)
DA068177 cerebellum .c 301 to 862 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA086851 cerebellum .c 301 to 864 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA530851 brain .c 301 to 905 2 to 606   capped   605/605
(100 %)
0 diff
(100 %id)
DA543514   .c 301 to 866 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA574940   .c 301 to 855 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA581825 lung .c 301 to 839 2 to 540   capped   539/541
(99 %)
2 diff
(99.7 %id)
BG829670 epithelioid carcinoma cell line, Pancreas .c 301 to 945 1 to 647       647/778
(83 %)
9 diff
(98.9 %id)
BI833579 pooled pancreas and spleen .c 301 to 1121 1 to 831       831/832
(99 %)
14 diff
(98.4 %id)
DA682608 ovary .c 301 to 868 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA689877   .c 301 to 828 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DA707263   .c 301 to 858 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA824912 pericardium .c 301 to 820 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
DA836516 placenta .c 301 to 795 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
DA905364   .c 301 to 862 2 to 563   capped   562/563
(99 %)
0 diff
(100 %id)
DA950907 Spleen .c 301 to 865 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA959394 Spleen .c 301 to 851 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB118368 thymus .c 301 to 861 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB195420 trachea .c 301 to 820 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
DA085933 cerebellum .c 302 to 778 2 to 478   capped   477/477
(100 %)
0 diff
(100 %id)
TI_57219030   .c 302 to 1237 70 to 1011       940/1035
(90 %)
36 diff
(96.6 %id)
DA682522 ovary .c 302 to 865 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA265354 caudate nucleus .c 303 to 855 2 to 554   capped   553/554
(99 %)
2 diff
(99.7 %id)
DA599002   .c 303 to 829 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA606279   .c 303 to 782 2 to 481   capped   480/480
(100 %)
0 diff
(100 %id)
DA644273   .c 303 to 868 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB038008 testis .c 303 to 877 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB189689 lung, tumor tissue .c 303 to 872 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BI754060 brain .c 304 to 1237 1 to 940       938/964
(97 %)
31 diff
(96.8 %id)
DR002381 fetal brain .c 304 to 1019 9 to 724       716/724
(98 %)
6 diff
(99.2 %id)
DB474309 hippocampus .c 305 to 791 1 to 487       487/487
(100 %)
0 diff
(100 %id)
DB485822 hypothalamus .c 305 to 744 1 to 441       441/441
(100 %)
5 diff
(98.9 %id)
CD624425   .c 306 to 979 1 to 674       674/678
(99 %)
11 diff
(98.4 %id)
DB015026 esophageal, tumor tissue .c 306 to 778 2 to 474   capped   473/473
(100 %)
3 diff
(99.4 %id)
CN304820 embryonic stem cells, cell lines H1, H7, andH9 .c 308 to 927 1 to 621       621/621
(100 %)
1 diff
(99.9 %id)
BE257786 eye, retinoblastoma .c 308 to 935 1 to 628       628/632
(99 %)
3 diff
(99.6 %id)
BX419356 brain, fetal brain .c 311 to 1151 1 to 840       840/840
(100 %)
1 diff
(99.9 %id)
BX440830 brain, fetal brain .c 312 to 1300 1 to 978       980/1005
(97 %)
15 diff
(98.6 %id)
BG419577 Kidney, renal cell adenocarcinoma .c 312 to 961 1 to 651       651/651
(100 %)
3 diff
(99.6 %id)
AL557718 T cells (Jurkat cell line), T cells from T cell leukemia .c 313 to 994 1 to 682       682/682
(100 %)
2 diff
(99.8 %id)
CR590233 Placenta Cot 25-normalized .c 314 to 2105 1 to 1792 exact     1792/1792
(100 %)
0 diff
(100 %id)
CR613129 Placenta Cot 25-normalized .c 314 to 2114 1 to 1801 exact     1801/1801
(100 %)
0 diff
(100 %id)
AL549869 placenta, Placenta Cot 25-normalized .c 314 to 1241 1 to 925   fully sequenced,   925/925
(100 %)
8 diff
(99.2 %id)
AL549904 placenta, Placenta Cot 25-normalized .c 314 to 1209 1 to 894   fully sequenced,   894/894
(100 %)
1 diff
(99.9 %id)
BQ067048 brain .c 315 to 1235 11 to 943       933/1041
(89 %)
29 diff
(97.3 %id)
AA316846 colon .c 316 to 637 1 to 321       321/322
(99 %)
2 diff
(99.4 %id)
BM857011 stomach .c 316 to 592 1 to 277       277/277
(100 %)
0 diff
(100 %id)
AW954742   .c 317 to 862 1 to 545       545/621
(87 %)
5 diff
(99.2 %id)
DN995157 brain, whole brain .c 317 to 1020 8 to 711       704/711
(99 %)
6 diff
(99.2 %id)
CR747464 B-cell, chronic lymphotic leukemia .c 318 to 691 1 to 374       374/379
(98 %)
1 diff
(99.8 %id)
BM541660 leiomyosarcoma, uterus .c 319 to 1125 40 to 854       815/1128
(72 %)
27 diff
(97.7 %id)
BQ670572 epidermoid carcinoma, cell line, salivary gland .c 319 to 1151 15 to 851       837/923
(90 %)
12 diff
(98.7 %id)
TI_57152695   .c 319 to 1107 25 to 813       789/813
(97 %)
6 diff
(99.3 %id)
BI085476 astrocytoma grade IV, cell line, brain .c 320 to 990 1 to 671       671/671
(100 %)
2 diff
(99.8 %id)
DA160309 amygdala .c 321 to 820 2 to 501   capped   500/500
(100 %)
0 diff
(100 %id)
BE887121 leiomyosarcoma, uterus .c 321 to 1043 1 to 731       727/858
(84 %)
15 diff
(98.3 %id)
BU526595 epidermoid carcinoma, cell line, lung .c 321 to 1217 1 to 903       903/917
(98 %)
13 diff
(98.6 %id)
DB242937 stomach, tumor tissue .c 321 to 861 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA890254 rectum .c 323 to 885 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB013531 esophageal, tumor tissue .c 323 to 880 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DB030059 testis .c 323 to 915 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
BI764589 pooled colon, kidney, stomach .c 325 to 1107 1 to 783       783/783
(100 %)
0 diff
(100 %id)
CN304824 embryonic stem cells, cell lines H1, H7, andH9 .c 326 to 1055 1 to 730       730/730
(100 %)
1 diff
(99.9 %id)
CR606907 fetal brain .c 326 to 2125 1 to 1800 exact     1800/1800
(100 %)
0 diff
(100 %id)
AL540278 brain, fetal brain .c 326 to 1208 1 to 882   fully sequenced,   882/882
(100 %)
1 diff
(99.9 %id)
BE561969 Burkitt lymphoma, lymph .c 328 to 1107 35 to 823       787/1039
(75 %)
32 diff
(97.0 %id)
BU196033 melanotic melanoma, cell line, skin .c 328 to 1145 1 to 823       823/874
(94 %)
16 diff
(98.2 %id)
BP872037 embryonal kidney .c 329 to 910 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BE906545 epithelioid carcinoma, Pancreas .c 329 to 1003 1 to 672       672/718
(93 %)
9 diff
(98.8 %id)
BU164551 large cell carcinoma, lung .c 329 to 1225 1 to 899       899/899
(100 %)
9 diff
(99.0 %id)
DA374670 thalamus .c 330 to 883 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BX421807 T cells (Jurkat cell line) .c 331 to 1327 23 to 1010       988/1017
(97 %)
16 diff
(98.5 %id)
DA961034 Spleen .c 331 to 885 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA045224 bladder .c 332 to 810 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
DA705775   .c 332 to 820 2 to 490   capped   489/489
(100 %)
1 diff
(99.8 %id)
DA838281 placenta .c 332 to 872 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA937383 Spleen .c 332 to 905 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA954450 Spleen .c 332 to 875 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA964288 stomach .c 332 to 895 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA967412 stomach .c 332 to 900 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA141223 alzheimer cortex .c 333 to 879 2 to 548   capped   547/547
(100 %)
5 diff
(99.1 %id)
DA590537 lung .c 333 to 810 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
BF315778 brain, neuroblastoma .c 333 to 1038 1 to 705       705/1028
(68 %)
17 diff
(98.4 %id)
DB010875 colon, tumor tissue .c 333 to 902 2 to 573   capped   572/572
(100 %)
4 diff
(99.4 %id)
TI_57239005   .c 334 to 1219 23 to 911       889/964
(92 %)
17 diff
(98.3 %id)
CB151857 cervix, Uterine .c 335 to 1022 1 to 688       688/688
(100 %)
1 diff
(99.9 %id)
DA597294   .c 335 to 882 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA705017   .c 335 to 861 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA002551   .c 336 to 917 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
AK315138   .c 336 to 1570 1 to 1235 exact     1235/1235
(100 %)
0 diff
(100 %id)
CB151541 cervix, Uterine .c 336 to 736 1 to 402       402/403
(99 %)
39 diff
(90.4 %id)
DA497795 brain .c 336 to 909 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
BE882152 leiomyosarcoma, uterus .c 336 to 1045 1 to 705       705/705
(100 %)
7 diff
(99.1 %id)
DA617107   .c 336 to 934 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
CB129782 Liver .c 336 to 873 1 to 538       538/538
(100 %)
3 diff
(99.5 %id)
CB150369 Liver .c 336 to 817 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
CB147067 Liver .c 336 to 941 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
DA821855 pericardium .c 336 to 893 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA997720   .c 336 to 899 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB013918 esophageal, tumor tissue .c 336 to 913 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DB049118 testis .c 336 to 868 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DB246162 uterus, tumor tissue .c 336 to 885 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA038720   .c 337 to 901 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA045534 bladder .c 337 to 913 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA050137   .c 337 to 908 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA078702 cerebellum .c 337 to 862 2 to 527   capped   526/535
(98 %)
1 diff
(99.9 %id)
DA146939 amygdala .c 337 to 917 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DA207438 brain .c 337 to 915 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA254391 caudate nucleus .c 337 to 899 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA262797 caudate nucleus .c 337 to 885 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA427691 colon .c 337 to 910 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA546813   .c 337 to 893 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BQ215585 large cell carcinoma, lung .c 337 to 1055 18 to 740       723/851
(84 %)
16 diff
(98.2 %id)
DA604165   .c 337 to 842 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
DA605259   .c 337 to 588 2 to 253   capped   252/252
(100 %)
0 diff
(100 %id)
DA605948   .c 337 to 906 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA609516   .c 337 to 820 2 to 485   capped   484/484
(100 %)
1 diff
(99.8 %id)
DA687319   .c 337 to 869 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA704044   .c 337 to 855 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
DA845393 placenta .c 337 to 879 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA848700 placenta .c 337 to 906 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA875481 Prostate .c 337 to 898 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA909177   .c 337 to 878 2 to 543   capped   542/545
(99 %)
1 diff
(99.9 %id)
DA913803   .c 337 to 889 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB189497 lung, tumor tissue .c 337 to 887 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB244897 uterus, tumor tissue .c 337 to 900 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB248291 uterus .c 337 to 934 2 to 599   capped   598/598
(100 %)
1 diff
(99.9 %id)
DT218843 brain .c 338 to 998 1 to 661       661/661
(100 %)
0 diff
(100 %id)
BM788695 stomach .c 338 to 731 1 to 394       394/394
(100 %)
0 diff
(100 %id)
DA695016   .c 339 to 882 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BI916106 brain .c 341 to 1219 1 to 882       882/935
(94 %)
11 diff
(98.9 %id)
CR609653 T cells (Jurkat cell line) Cot10-normalized .c 342 to 2107 1 to 1766 exact     1766/1766
(100 %)
0 diff
(100 %id)
AL558948 T cells from T cell leukemia .c 342 to 1264 1 to 922       922/922
(100 %)
4 diff
(99.6 %id)
ES314439 occipital scalp hair, skin .c 343 to 477 1 to 133       133/147
(90 %)
3 diff
(98.0 %id)
DA977516 synovial membrane tissue from rheumatioidarthritis .c 344 to 918 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BE562184 Burkitt lymphoma, lymph .c 346 to 1150 48 to 863       816/981
(83 %)
28 diff
(97.2 %id)
BE545079 cervical carcinoma cell line, cervix .c 348 to 1117 1 to 761       765/761
(100 %)
19 diff
(97.6 %id)
BC023584 Lymph, Burkitt lymphoma .c 352 to 2147 1 to 1796 exact available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1796/1796
(100 %)
0 diff
(100 %id)
BC021047 Lymph, Burkitt lymphoma .c 352 to 2147 1 to 1798 R3T T4D S5C K6Q D7K ... available from MGC, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 1798/1798
(100 %)
3 diff
(99.9 %id)
BU177144 melanotic melanoma, skin .c 355 to 1151 1 to 797       797/870
(91 %)
8 diff
(99.1 %id)
BE547847 cervical carcinoma cell line, cervix .c 356 to 933 1 to 590       510/923
(55 %)
21 diff
(97.8 %id)
CN304821 embryonic stem cells, cell lines H1, H7, andH9 .c 357 to 1020 1 to 664       664/664
(100 %)
1 diff
(99.9 %id)
CN482383 eye .c 358 to 929 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BE549222 cervical carcinoma cell line, cervix .c 358 to 950 1 to 592       592/676
(87 %)
14 diff
(98.0 %id)
BX350317   .c 360 to 1232 874 to 1       874/874
(100 %)
24 diff
(97.3 %id)
DR156055 human embryonic stem cells differentiated toan early endodermal cell type .c 363 to 975 1 to 613       613/613
(100 %)
0 diff
(100 %id)
BE896459 melanotic melanoma, skin .c 366 to 862 1 to 500       500/1134
(44 %)
7 diff
(99.4 %id)
BM854098 Ascites, stomach .c 368 to 1022 1 to 655       655/655
(100 %)
1 diff
(99.9 %id)
DA360589 subthalamic nucleus .c 369 to 919 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA579711   .c 375 to 939 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB246377 uterus, tumor tissue .c 375 to 948 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BE787450 large cell carcinoma, lung .c 387 to 1005 1 to 618       618/619
(99 %)
2 diff
(99.7 %id)
DA564835 heart .c 389 to 897 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DB211938 trachea .c 389 to 933 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB245127 uterus, tumor tissue .c 398 to 948 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB192276 ovary, tumor tissue .c 406 to 967 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BE268439 Burkitt lymphoma, lymph .c 411 to 1044 96 to 738   available from MGC,   643/752
(85 %)
22 diff
(97.1 %id)
BG751645 eye, normal pigmented retinal epithelium .c 411 to 900 1 to 504       502/516
(97 %)
17 diff
(96.8 %id)
BE545922 cervical carcinoma cell line, cervix .c 416 to 702 1 to 294       294/321
(91 %)
14 diff
(95.7 %id)
BG489882 large cell carcinoma, lung .c 419 to 1207 1 to 801       799/801
(99 %)
21 diff
(97.4 %id)
CB150363 Liver .c 420 to 800 1 to 380       380/380
(100 %)
13 diff
(96.6 %id)
DB114685 thymus .c 421 to 976 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA065290 cerebellum .c 425 to 982 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BE397667 Burkitt lymphoma, lymph .c 425 to 1044 119 to 761       566/895
(63 %)
28 diff
(96.9 %id)
BI712960 Pancreas, Purified pancreatic islet .c 428 to 831 1 to 403     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 403/404
(99 %)
11 diff
(97.3 %id)
BG256101 adenocarcinoma, cell line, Prostate .c 435 to 1151 1 to 719       717/967
(74 %)
11 diff
(98.9 %id)
CB147051 Liver .c 455 to 809 1 to 355       355/355
(100 %)
4 diff
(98.9 %id)
CN304825 embryonic stem cells, cell lines H1, H7, andH9 .c 491 to 1208 3 to 720       718/720
(99 %)
6 diff
(99.2 %id)
BG324080 Kidney, renal cell adenocarcinoma .c 504 to 1344 1 to 830       830/1150
(72 %)
35 diff
(97.0 %id)
BQ053597 blood, natural killer cells, cell line .c 515 to 1418 1 to 907       907/976
(92 %)
8 diff
(99.2 %id)
CB135983 Liver .c 520 to 1102 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
N71797 multiple sclerosis lesions .c 523 to 974 1 to 456       454/456
(99 %)
12 diff
(97.4 %id)
BE313120 brain, neuroblastoma .c 523 to 1212 1 to 687       687/688
(99 %)
21 diff
(97.0 %id)
AA386390 lung .c 567 to 862 1 to 298       298/345
(86 %)
3 diff
(99.2 %id)
BG026781 Bone, osteosarcoma, cell line .c 576 to 1344 1 to 761       761/1061
(71 %)
28 diff
(97.4 %id)
TI_1948217973   .c 577 to 1266 133 to 823   fully sequenced,   691/823
(83 %)
6 diff
(99.3 %id)
TI_1948218140   .c 577 to 1079 135 to 637   fully sequenced,   503/637
(78 %)
6 diff
(99.1 %id)
TI_1948218482   .c 577 to 1079 137 to 639   fully sequenced,   503/639
(78 %)
6 diff
(99.1 %id)
EL735230 mixed .c 581 to 1267 1 to 682       682/686
(99 %)
6 diff
(99.2 %id)
BE272159 adenocarcinoma cell line, ovary .c 599 to 1151 380 to 926       547/1034
(52 %)
27 diff
(97.4 %id)
BE409599 choriocarcinoma, placenta .c 599 to 1119 295 to 818       524/818
(64 %)
14 diff
(98.3 %id)
BI600923 brain, hypothalamus .c 600 to 1003 397 to 803       407/1005
(40 %)
17 diff
(98.4 %id)
BE397422 Burkitt lymphoma, lymph .c 603 to 1185 296 to 869       574/1064
(53 %)
27 diff
(97.5 %id)
EC458205 Prostate .c 627 to 702 1 to 76       76/91
(83 %)
1 diff
(99.0 %id)
BQ065643 lymph, lymphoma, cell line .c 677 to 1337 1 to 662       662/1137
(58 %)
13 diff
(98.9 %id)
BM843860 lymph node, stomach .c 690 to 1232 1 to 543       543/543
(100 %)
5 diff
(99.1 %id)
H10484 whole brain .c 743 to 1197 30 to 493       464/493
(94 %)
15 diff
(97.0 %id)
BE379172 endometrium, adenocarcinoma cell line, uterus .c 754 to 1528 1 to 770       770/808
(95 %)
20 diff
(97.6 %id)
AA344412 gall bladder .c 768 to 941 1 to 173       173/176
(98 %)
6 diff
(96.6 %id)
TI_1948218313   .c 771 to 1574 931 to 118       814/1304
(62 %)
12 diff
(99.1 %id)
BQ379455 uterus_tumor .c 832 to 1136 1 to 306       306/306
(100 %)
16 diff
(94.8 %id)
BU595119 mixed (pool of 40 RNAs) .c 841 to 1339 1 to 502       502/970
(51 %)
10 diff
(99.0 %id)
BM821837 stomach .c 842 to 1096 1 to 255       255/255
(100 %)
3 diff
(98.9 %id)
BM821852 stomach .c 844 to 1151 1 to 309       309/313
(98 %)
7 diff
(97.8 %id)
BM557593 amelanotic melanoma, cell line, skin .c 854 to 1878 1 to 1035       1035/1038
(99 %)
23 diff
(97.8 %id)
BM555988 amelanotic melanoma, cell line, skin .c 854 to 1811 1 to 964       964/1130
(85 %)
24 diff
(97.9 %id)
BM807951 amelanotic melanoma, cell line, skin .c 855 to 1537 1 to 684   AAA   684/1213
(56 %)
2 diff
(99.9 %id)
BI334432 cervical carcinoma cell line, cervix .c 860 to 1640 1 to 778       778/778
(100 %)
10 diff
(98.8 %id)
BQ311759 breast_normal .c 873 to 1331 1 to 459       459/459
(100 %)
0 diff
(100 %id)
BQ311760 breast_normal .c 873 to 1327 1 to 456       456/457
(99 %)
8 diff
(98.3 %id)
BF804689 colon_ins .c 885 to 1215 345 to 15     Submitted on the opposite strand 331/362
(91 %)
3 diff
(99.2 %id)
BG113653 Bone, osteosarcoma, cell line .c 925 to 1537 1 to 608       608/891
(68 %)
11 diff
(98.8 %id)
CD512017 Pooled-Skin .c 940 to 1632 1 to 702       702/882
(79 %)
15 diff
(98.3 %id)
BE787912 large cell carcinoma, lung .c 941 to 1537 1 to 585       585/752
(77 %)
15 diff
(98.1 %id)
AU129508   .c 945 to 1650 2 to 712   fully sequenced, capped   711/711
(100 %)
8 diff
(98.9 %id)
CB148628 Liver .c 960 to 1537 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BM916719 amelanotic melanoma, cell line, skin .c 983 to 1722 12 to 755       744/1195
(62 %)
27 diff
(97.8 %id)
BE937101 stomach_normal .c 995 to 1301 23 to 328       306/330
(92 %)
8 diff
(97.6 %id)
TI_1948218141   .c 1018 to 1574 676 to 120   fully sequenced,   557/676
(82 %)
0 diff
(100 %id)
TI_1948218483   .c 1018 to 1574 674 to 119   fully sequenced,   556/674
(82 %)
0 diff
(100 %id)
BG109030 Bone, osteosarcoma, cell line .c 1062 to 1627 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
BI256901 cervical carcinoma cell line, cervix .c 1086 to 1944 1 to 861       861/861
(100 %)
14 diff
(98.4 %id)
CX758453 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 1137 to 1806 1 to 665       665/835
(79 %)
58 diff
(93.1 %id)
EC505613 Prostate .c 1146 to 1252 107 to 1       107/107
(100 %)
2 diff
(98.2 %id)
BX369424   .c 1151 to 2070 1 to 919       919/919
(100 %)
16 diff
(98.3 %id)
AL580660 T cells from T cell leukemia .c 1165 to 2084 935 to 23       913/942
(96 %)
7 diff
(99.3 %id)
AL568309 brain, fetal brain .c 1178 to 2125 951 to 1   fully sequenced,   951/951
(100 %)
5 diff
(99.5 %id)
BI256910 cervical carcinoma cell line, cervix .c 1178 to 2001 1 to 827       827/1002
(82 %)
9 diff
(99.2 %id)
AL573921 placenta, Placenta Cot 25-normalized .c 1180 to 2089 934 to 26   fully sequenced,   909/934
(97 %)
7 diff
(99.3 %id)
AL524014 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1205 to 2178 969 to 1   fully sequenced,   969/969
(100 %)
13 diff
(98.7 %id)
AL573899 placenta, Placenta Cot 25-normalized .c 1205 to 2105 897 to 1   fully sequenced,   897/897
(100 %)
6 diff
(99.4 %id)
TI_1948217974   .c 1205 to 1574 489 to 121   fully sequenced,   369/489
(75 %)
0 diff
(100 %id)
CN304822 embryonic stem cells, DMSO-treated H9 cellline .c 1230 to 1755 56 to 581       526/581
(90 %)
7 diff
(98.8 %id)
AI457790 carcinoid, lung .c 1241 to 1500 170 to 430     Submitted on the opposite strand 261/430
(60 %)
7 diff
(98.4 %id)
BG256004 adenocarcinoma, cell line, Prostate .c 1253 to 1998 1 to 750       750/993
(75 %)
36 diff
(96.4 %id)
CD624426   .c 1255 to 1841 15 to 601       587/601
(97 %)
7 diff
(98.9 %id)
BG255967 adenocarcinoma, cell line, Prostate .c 1282 to 2049 1 to 771       771/976
(78 %)
33 diff
(96.7 %id)
AA322681 brain, cerebellum .c 1286 to 1619 1 to 334       334/334
(100 %)
2 diff
(99.5 %id)
AW960875   .c 1287 to 1714 1 to 429       429/433
(99 %)
14 diff
(96.8 %id)
TI_149310637   .c 1292 to 2137 934 to 95   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 840/954
(88 %)
15 diff
(98.5 %id)
BG109620 Bone, osteosarcoma, cell line .c 1305 to 1991 1 to 688       688/731
(94 %)
8 diff
(99.0 %id)
BU149314 hepatocellular carcinoma, cell line, Liver .c 1326 to 2142 1 to 817   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 817/817
(100 %)
0 diff
(100 %id)
BQ892510 hepatocellular carcinoma, cell line, Liver .c 1326 to 2142 1 to 817   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 817/817
(100 %)
1 diff
(99.9 %id)
CD624427   .c 1330 to 1841 508 to 1       510/508
(100 %)
7 diff
(98.7 %id)
BX412911 brain, fetal brain .c 1334 to 2183 853 to 5       849/857
(99 %)
12 diff
(98.6 %id)
TI_149298266   .c 1344 to 2142 892 to 99   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 794/920
(86 %)
11 diff
(98.9 %id)
TI_154113056   .c 1344 to 2147 891 to 95   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 797/927
(85 %)
14 diff
(98.5 %id)
AI765197 2 pooled tumors (clear cell type), Kidney .c 1373 to 2148 802 to 26       777/802
(96 %)
21 diff
(97.4 %id)
AI675401 Prostate .c 1403 to 2142 768 to 29   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 740/740
(100 %)
24 diff
(96.8 %id)
AL579697 T cells (Jurkat cell line), T cells from T cell leukemia .c 1414 to 2125 712 to 1       712/712
(100 %)
2 diff
(99.8 %id)
BU688915 lung .c 1431 to 2137 725 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 707/707
(100 %)
0 diff
(100 %id)
BE856065 Prostate .c 1463 to 2137 681 to 6       676/681
(99 %)
20 diff
(97.1 %id)
CA448662 Chondrosarcoma, Left Pelvis .c 1464 to 2147 702 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 684/684
(100 %)
0 diff
(100 %id)
BM983035 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1465 to 2142 696 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 678/678
(100 %)
0 diff
(100 %id)
AW299934 Kidney .c 1493 to 2142 650 to 1       650/653
(99 %)
9 diff
(98.7 %id)
AW269326 Kidney .c 1495 to 2143 651 to 2       650/674
(96 %)
4 diff
(99.5 %id)
AW818500 stomach .c 1506 to 1896 395 to 7       389/413
(94 %)
1 diff
(99.8 %id)
AW818614 stomach .c 1512 to 1896 16 to 401       386/407
(94 %)
18 diff
(95.6 %id)
CA437714 lung, Metastatic Chondrosarcoma .c 1535 to 2187 671 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 653/653
(100 %)
2 diff
(99.7 %id)
CA423266 cell lines, Chondrosarcoma .c 1535 to 2192 676 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 658/658
(100 %)
0 diff
(100 %id)
BX456038 T cells (Jurkat cell line) .c 1579 to 2109 552 to 22       531/713
(74 %)
0 diff
(100 %id)
H09726 whole brain .c 1579 to 2149 578 to 8       571/611
(93 %)
0 diff
(100 %id)
BI085698 astrocytoma grade IV, cell line, brain .c 1580 to 2071 508 to 3       506/580
(87 %)
30 diff
(94.9 %id)
DB353938   .c 1586 to 2142 552 to 1       552/578
(95 %)
18 diff
(96.9 %id)
CR748501   .c 1596 to 2192 611 to 15   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 597/597
(100 %)
2 diff
(99.7 %id)
AI492153 B-cell, chronic lymphotic leukemia .c 1597 to 2142 561 to 16   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 546/546
(100 %)
0 diff
(100 %id)
BQ774425 Chondrosarcoma Grade II, Left Pelvis .c 1608 to 2137 548 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 530/530
(100 %)
0 diff
(100 %id)
CN304826 embryonic stem cells, cell lines H1, H7, andH9 .c 1612 to 2142 541 to 11   AAA Submitted on the opposite strand 531/531
(100 %)
8 diff
(98.5 %id)
DB366795   .c 1620 to 2142 516 to 1   fully sequenced,   516/516
(100 %)
11 diff
(97.9 %id)
AW274960 pooled germ cell tumors .c 1626 to 2143 518 to 1       518/518
(100 %)
0 diff
(100 %id)
AI862629 2 pooled tumors (clear cell type), Kidney .c 1628 to 2143 518 to 3       516/518
(99 %)
0 diff
(100 %id)
BI791548 Pancreas, Purified pancreatic islet .c 1664 to 2137 485 to 11   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 475/475
(100 %)
8 diff
(98.4 %id)
DB330782 skeletal muscle .c 1665 to 2137 476 to 1       476/476
(100 %)
8 diff
(98.4 %id)
BU608584 Human Lung Epithelial cells, lung .c 1668 to 2142 493 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 475/478
(99 %)
0 diff
(100 %id)
TI_154091901   .c 1669 to 2142 619 to 146   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 474/475
(99 %)
4 diff
(99.2 %id)
DB543127 hippocampus .c 1670 to 2147 1 to 478     Submitted on the opposite strand 478/478
(100 %)
0 diff
(100 %id)
N41839.
matches multiple genes
placenta .c 1670 to 2141 1 to 485     also hits gene CLPP 485/492
(98 %)
30 diff
(94.0 %id)
AI241141 Kidney .c 1675 to 2137 463 to 1       463/463
(100 %)
3 diff
(99.4 %id)
BI002862 head_normal .c 1677 to 1809 16 to 145       130/145
(89 %)
6 diff
(95.9 %id)
DB575551 hypothalamus .c 1682 to 2147 1 to 467   AAA Submitted on the opposite strand 467/467
(100 %)
6 diff
(98.8 %id)
DB521748 testis .c 1690 to 2147 1 to 458     Submitted on the opposite strand 458/458
(100 %)
3 diff
(99.4 %id)
BP386829 pancreatic islet .c 1692 to 2189 1 to 498     Submitted on the opposite strand 498/500
(99 %)
1 diff
(99.8 %id)
BQ005103 Chondrosarcoma, Left Pelvis .c 1693 to 2142 468 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 450/450
(100 %)
0 diff
(100 %id)
AW969747   .c 1697 to 2142 574 to 129   AAA Submitted on the opposite strand 446/446
(100 %)
0 diff
(100 %id)
BF432044 pooled .c 1702 to 2143 444 to 3       442/444
(99 %)
0 diff
(100 %id)
DB531474 hippocampus .c 1706 to 2142 1 to 435     Submitted on the opposite strand 435/435
(100 %)
3 diff
(99.4 %id)
BG150463 pooled germ cell tumors .c 1710 to 2149 442 to 3       440/442
(99 %)
0 diff
(100 %id)
DB554539 hypothalamus .c 1713 to 2147 1 to 435   AAA Submitted on the opposite strand 435/435
(100 %)
25 diff
(94.3 %id)
AA838648 epithelium (cell line), Prostate .c 1713 to 2147 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AA934695 2 pooled tumors (clear cell type), Kidney .c 1713 to 2142 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AW439537 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1714 to 2142 447 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 429/429
(100 %)
2 diff
(99.6 %id)
AI985276 Kidney .c 1716 to 2142 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI090898 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1717 to 2142 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
DB512844 testis .c 1722 to 2142 1 to 420     Submitted on the opposite strand 420/420
(100 %)
3 diff
(99.3 %id)
AI950234 pooled germ cell tumors .c 1722 to 2147 445 to 20   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 426/426
(100 %)
1 diff
(99.8 %id)
AW069656 bone marrow stroma .c 1723 to 2147 443 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 425/425
(100 %)
0 diff
(100 %id)
AW594210 pooled germ cell tumors .c 1725 to 2149 427 to 3       425/427
(99 %)
0 diff
(100 %id)
AA975352 2 pooled tumors (clear cell type), Kidney .c 1730 to 2143 416 to 3       414/416
(99 %)
0 diff
(100 %id)
AI394621 B-cell, chronic lymphotic leukemia .c 1735 to 2142 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AI066674 senescent fibroblast .c 1736 to 2144 414 to 6       409/414
(98 %)
0 diff
(100 %id)
CA434464 lung, Lung Focal Fibrosis .c 1739 to 2142 422 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 404/404
(100 %)
0 diff
(100 %id)
AA961218 carcinoid, lung .c 1747 to 2146 400 to 1       400/400
(100 %)
0 diff
(100 %id)
AI682493 Prostate .c 1750 to 2142 414 to 22   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 393/393
(100 %)
3 diff
(99.3 %id)
AI129918 uterus .c 1757 to 2142 412 to 27   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 386/386
(100 %)
5 diff
(98.8 %id)
AI218207 pooled .c 1758 to 2149 393 to 2       392/393
(99 %)
0 diff
(100 %id)
AI421656 brain, glioblastoma (pooled) .c 1761 to 2149 391 to 5       387/391
(98 %)
0 diff
(100 %id)
AA156126   .c 1768 to 2143 378 to 3       376/379
(99 %)
0 diff
(100 %id)
AI094968 brain, glioblastoma (pooled) .c 1774 to 2147 392 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 374/374
(100 %)
3 diff
(99.2 %id)
AA884675 pooled .c 1779 to 2142 377 to 14   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 364/364
(100 %)
0 diff
(100 %id)
AI674813 Prostate .c 1779 to 2142 382 to 20   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 363/363
(100 %)
2 diff
(99.5 %id)
AI080363 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1785 to 2138 356 to 3       354/356
(99 %)
0 diff
(100 %id)
AI272037 Kidney .c 1785 to 2137 353 to 1       353/353
(100 %)
0 diff
(100 %id)
H61174.
matches multiple genes
ovarian tumor, ovary .c 1787 to 2130 351 to 1     also hits gene TYK2 351/352
(99 %)
16 diff
(95.5 %id)
AI457868 carcinoid, lung .c 1788 to 2142 365 to 11   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 355/355
(100 %)
7 diff
(98.1 %id)
AW316577 brain, three pooled meningiomas .c 1790 to 2142 373 to 21   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 353/353
(100 %)
7 diff
(98.1 %id)
DB561323 hypothalamus .c 1791 to 2145 30 to 382     Submitted on the opposite strand 353/384
(91 %)
3 diff
(99.3 %id)
AI420152 Prostate .c 1791 to 2142 352 to 1       352/352
(100 %)
0 diff
(100 %id)
AI867150 2 pooled tumors (clear cell type), Kidney .c 1800 to 2142 361 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 343/343
(100 %)
2 diff
(99.5 %id)
BM127840 Islets of Langerhans, Pancreas .c 1801 to 2187 407 to 21   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
DB533980 hippocampus .c 1804 to 2142 15 to 361     Submitted on the opposite strand 347/361
(96 %)
6 diff
(98.4 %id)
AA483601 Ewing's sarcoma .c 1806 to 2142 348 to 12   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 337/337
(100 %)
2 diff
(99.5 %id)
AI761283 B-cell, chronic lymphotic leukemia .c 1807 to 2188 382 to 1       382/382
(100 %)
0 diff
(100 %id)
AA992821   .c 1810 to 2147 355 to 18   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 338/338
(100 %)
1 diff
(99.8 %id)
AI364890 pooled germ cell tumors .c 1814 to 2149 338 to 4       335/338
(99 %)
0 diff
(100 %id)
AI913685 Kidney .c 1815 to 2192 389 to 1       389/389
(100 %)
13 diff
(96.7 %id)
AI202819 anaplastic oligodendroglioma, brain .c 1816 to 2194 376 to 1   tiling clone,   376/376
(100 %)
3 diff
(99.3 %id)
AI262669 adenocarcinoma, colon .c 1827 to 2142 317 to 1       317/317
(100 %)
5 diff
(98.5 %id)
AI445608 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1829 to 2147 342 to 24   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 319/319
(100 %)
1 diff
(99.7 %id)
AI474676 Kidney .c 1835 to 2142 308 to 1       308/308
(100 %)
0 diff
(100 %id)
AI040408 parathyroid gland, parathyroid tumor .c 1865 to 2142 288 to 11   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 278/278
(100 %)
1 diff
(99.7 %id)
AI538653 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1868 to 2142 301 to 27   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 275/275
(100 %)
4 diff
(98.6 %id)
AW301260 Kidney .c 1899 to 2147 262 to 14   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 249/249
(100 %)
4 diff
(98.4 %id)
CA428909 Cell Line, Chondrosarcoma .c 1901 to 2142 260 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 242/242
(100 %)
0 diff
(100 %id)
AI867591 Prostate .c 1931 to 2142 230 to 19   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 212/212
(100 %)
2 diff
(99.1 %id)
BE041651 carcinoid, lung .c 1931 to 2138 212 to 7       206/212
(97 %)
0 diff
(100 %id)
AW207546   .c 1952 to 2138 202 to 17       186/202
(92 %)
0 diff
(100 %id)
AI933791 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1972 to 2142 181 to 12   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 170/170
(100 %)
1 diff
(99.5 %id)
AI914874 ovary, tumor, 5 pooled (see description) .c 1974 to 2192 220 to 1       220/220
(100 %)
6 diff
(97.3 %id)
AA935104 metastatic prostate bone lesion .c 1988 to 2188 201 to 1       201/205
(98 %)
1 diff
(99.6 %id)
AA876749 metastatic prostate bone lesion .c 1988 to 2188 201 to 1       201/204
(98 %)
3 diff
(98.6 %id)
CR600255 T cells (Jurkat cell line) .d 1 to 1807 1 to 1807 exact tiling clone,   1807/1807
(100 %)
0 diff
(100 %id)
BX464685 T cells (Jurkat cell line) .d 1 to 1019 1 to 1008       1010/1008
(100 %)
27 diff
(97.4 %id)
BM924261 pooled colon, kidney, stomach .d 125 to 1139 9 to 1030       1022/1128
(90 %)
22 diff
(98.1 %id)
AK024023   .e 1 to 1984 2 to 1984 Q61R tiling clone, available from FLJ,   1984/1984
(100 %)
2 diff
(99.9 %id)
NM_177439.1   .e 1 to 2050 2 to 2051 exact RefSeq,   2051/2051
(100 %)
0 diff
(100 %id)
AU143002   .e 1 to 773 2 to 779   capped   776/779
(99 %)
8 diff
(99.0 %id)
DA003286   .e 15 to 569 2 to 557   capped   556/557
(99 %)
2 diff
(99.7 %id)
DA745324   .e 16 to 575 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA634519 Kidney .e 26 to 579 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB055234 testis .e 35 to 585 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB465016 hippocampus .e 38 to 479 1 to 442       442/442
(100 %)
13 diff
(97.1 %id)
DA601706   .e 39 to 609 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA745852   .e 39 to 593 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB040564 testis .e 43 to 599 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AU126494   .e 45 to 620 2 to 577   capped   576/578
(99 %)
2 diff
(99.7 %id)
DB013347 esophageal, tumor tissue .e 45 to 621 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BI765938 pooled colon, kidney, stomach .e 62 to 749 14 to 701       688/701
(98 %)
6 diff
(99.2 %id)
TI_57149725   .e 62 to 749 14 to 701       688/701
(98 %)
6 diff
(99.2 %id)
BQ959762 leiomyosarcoma, uterus .e 71 to 918 1 to 851       851/935
(91 %)
17 diff
(98.2 %id)
BQ422831 melanotic melanoma, skin .e 77 to 887 1 to 816       816/883
(92 %)
6 diff
(99.4 %id)
DA025284   .e 79 to 643 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA699865   .e 79 to 597 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
DA895650 skeletal muscle .e 79 to 629 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BI256150 cervical carcinoma cell line, cervix .e 262 to 923 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
AF063015   .e 373 to 2050 1 to 1678 exact tiling clone,   1678/1678
(100 %)
0 diff
(100 %id)
NM_177434.1   .e 373 to 2050 1 to 1678 exact RefSeq,   1678/1678
(100 %)
0 diff
(100 %id)
BU189357 melanotic melanoma, skin .e 409 to 1186 1 to 781       781/866
(90 %)
15 diff
(98.3 %id)
TI_57189697   .e 519 to 1309 52 to 839       788/790
(99 %)
11 diff
(98.7 %id)
BI860554 breast, mammary adenocarcinoma, cell line .e 520 to 1309 1 to 787       787/789
(99 %)
11 diff
(98.7 %id)
CN304823 embryonic stem cells, cell lines H1, H7, andH9 .e 615 to 1222 1 to 608       608/608
(100 %)
4 diff
(99.4 %id)
BQ322639 colon_est .e 627 to 1148 17 to 534       518/534
(97 %)
6 diff
(98.9 %id)
BE562675 endometrium, adenocarcinoma cell line, uterus .e 636 to 1323 18 to 697       680/732
(92 %)
15 diff
(98.0 %id)
BQ322939 colon_est .e 665 to 1118 1 to 454       454/454
(100 %)
6 diff
(98.7 %id)
BM747769 stomach .e 690 to 1162 1 to 475       475/477
(99 %)
11 diff
(97.7 %id)
BM759812 stomach .e 690 to 1245 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BM832774 stomach .e 690 to 1243 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BM836015 stomach .e 690 to 1113 1 to 424       424/424
(100 %)
1 diff
(99.8 %id)
AA625495 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 765 to 1149 1 to 383       383/383
(100 %)
7 diff
(98.2 %id)
H62077 ovarian tumor, ovary .e 910 to 1330 1 to 431       431/431
(100 %)
16 diff
(96.3 %id)
AA292177 ovarian tumor, ovary .e 910 to 1504 1 to 596       596/596
(100 %)
4 diff
(99.4 %id)
BX464684 T cells (Jurkat cell line) .e 1000 to 1949 951 to 1       951/1052
(90 %)
22 diff
(98.0 %id)
AU160176   .e 1436 to 1984 546 to 1       546/546
(100 %)
14 diff
(97.5 %id)
AA399418 ovarian tumor, ovary .e 1546 to 1991 448 to 3       446/448
(99 %)
0 diff
(100 %id)
CR616867 Neuroblastoma Cot 25-normalized .f 1 to 1464 1 to 1464 exact tiling clone,   1464/1464
(100 %)
0 diff
(100 %id)
AL525097 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .f 1 to 655 1 to 654   fully sequenced,   654/654
(100 %)
3 diff
(99.6 %id)
AL525096 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .f 594 to 1464 872 to 1   fully sequenced,   872/872
(100 %)
11 diff
(98.8 %id)
BI050368 placenta_normal .f 640 to 946 313 to 4       310/313
(99 %)
0 diff
(100 %id)
AL702992 human skeletal muscle .g 1 to 738 1 to 739   tiling clone,   739/747
(98 %)
6 diff
(99.2 %id)
BQ946705 epidermoid carcinoma, cell line, lung .g 734 to 1539 1 to 808   tiling clone,   808/824
(98 %)
8 diff
(99.1 %id)
BF174711 blood .g 1380 to 1681 1 to 301   tiling clone,   301/301
(100 %)
1 diff
(99.7 %id)
BF743638 breast .g 1414 to 1845 10 to 440   tiling clone,   431/445
(96 %)
16 diff
(96.5 %id)
BE076093 breast .g 1444 to 1619 12 to 187       176/187
(94 %)
6 diff
(96.8 %id)
BI521234 pooled pancreas and spleen .h 1 to 793 1 to 790   tiling clone,   790/790
(100 %)
13 diff
(98.4 %id)
W16800 lung .h 32 to 441 1 to 408       408/457
(89 %)
8 diff
(98.3 %id)
R21321 whole brain .h 33 to 399 1 to 367     Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 367/418
(87 %)
18 diff
(95.7 %id)
BI522074 pooled pancreas and spleen .h 1005 to 1866 874 to 1   tiling clone,   874/877
(99 %)
23 diff
(97.4 %id)
N90133 lung .h 1510 to 1921 418 to 1   tiling clone,   418/420
(99 %)
7 diff
(98.4 %id)
R46366 whole brain .h 1564 to 1966 425 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 415/460
(90 %)
16 diff
(96.6 %id)
AK297486 brain .i 1 to 1427 1 to 1427 exact tiling clone,   1427/1427
(100 %)
2 diff
(99.9 %id)
DC352217 brain .i 1 to 537 1 to 537       537/537
(100 %)
0 diff
(100 %id)
DA091351 cerebellum .j 1 to 534 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DA602846   .j 1 to 298 2 to 299   tiling clone, capped   298/298
(100 %)
0 diff
(100 %id)
DB447729 testis .j 96 to 539 1 to 443       443/443
(100 %)
5 diff
(98.9 %id)
BM686802 eye, optic nerve .j 99 to 711 1 to 611   tiling clone, fully sequenced,   611/611
(100 %)
5 diff
(99.2 %id)
BM672978 eye, optic nerve .j 630 to 1088 477 to 19   tiling clone, fully sequenced, AAA   459/459
(100 %)
0 diff
(100 %id)
AV723177 hypothalamus .j 636 to 1088 1 to 453   AAA   453/453
(100 %)
4 diff
(99.2 %id)
AI219855 pooled .j 665 to 1088 437 to 14   AAA   424/424
(100 %)
4 diff
(99.1 %id)
BM020795 astrocytoma grade IV, cell line, brain .k 1 to 795 1 to 790 G13A Y14M D15T P16L E18R ... tiling clone,   790/790
(100 %)
15 diff
(98.2 %id)
TI_59387872   .k 2 to 795 125 to 913 G13A Y14M D15T P16L E18R ...     789/789
(100 %)
14 diff
(98.3 %id)
CB151401 cervix, Uterine .l 1 to 553 1 to 552 exact tiling clone,   552/552
(100 %)
2 diff
(99.7 %id)
BG699381 brain, hippocampus .m 89 to 598 217 to 744 A9G L11V R12C S13A R14L ... tiling clone,   678/755
(89 %)
26 diff
(96.6 %id)
DA057871 cerebellum .n 1 to 511 2 to 512 exact tiling clone, capped   511/511
(100 %)
0 diff
(100 %id)
CA424201 cell lines, Chondrosarcoma .o 1 to 573 593 to 19 P49X H50A H51S C52L A53C ... tiling clone, AAA   575/575
(100 %)
2 diff
(99.7 %id)
BF030706 hypernephroma, Kidney .p 1 to 680 1 to 678 G21A C22A F23L V24W A25P ... tiling clone,   678/751
(90 %)
32 diff
(95.8 %id)
AV758786 bone marrow .p 500 to 1280 64 to 839   tiling clone,   776/873
(88 %)
36 diff
(95.9 %id)
DB111524 thymus .q 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
BG910688 anaplastic oligodendroglioma with 1p/19qloss, brain .q 323 to 986 1 to 676 F35L G39R S40T L41P A42* tiling clone,   676/889
(76 %)
16 diff
(98.3 %id)
CN275760 embryonic stem cells, DMSO-treated H9 cellline .q 449 to 976 1 to 528   tiling clone,   528/528
(100 %)
6 diff
(98.9 %id)
DB159695 thymus .r 1 to 585 2 to 586 exact tiling clone, capped   585/585
(100 %)
1 diff
(99.9 %id)
BI910716 leukocyte .r 10 to 729 1 to 722 R25T N26E S27F N28Q S29L ...     722/722
(100 %)
4 diff
(99.5 %id)
TI_57237630   .r 10 to 729 36 to 757 R25T N26E S27F N28Q S29L ...     722/757
(95 %)
9 diff
(98.9 %id)
DA065568 cerebellum .r 35 to 595 2 to 562 exact capped   561/561
(100 %)
0 diff
(100 %id)
CA454429   .r 55 to 838 1 to 786 exact tiling clone,   786/916
(85 %)
4 diff
(99.6 %id)
AA047779 heart .s-u 1 to 197 1 to 197   tiling clone,   197/197
(100 %)
1 diff
(99.5 %id)
AA057797 heart .s-u 429 to 711 285 to 1   tiling clone,   285/304
(93 %)
2 diff
(99.4 %id)
DA245464 brain .t-u 1 to 542 7 to 549 exact tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
DA000532   Gene FTSJ1, variant not shown       capped Suspected internal deletion, this clone was ignored    
BE930100 placenta_normal Gene FTSJ1, variant not shown         Suspected internal deletion, this clone was ignored    
AI352409 pooled germ cell tumors Gene FTSJ1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI949931 2 pooled tumors (clear cell type), Kidney Gene FTSJ1, variant not shown         This clone was ignored    
AW137692   Gene FTSJ1, variant not shown       AAA This clone was ignored    
AW206051   Gene FTSJ1, variant not shown       AAA This clone was ignored    
BE858005 Prostate Gene FTSJ1, variant not shown         This clone was ignored    
BM922980 leukocyte Gene FTSJ1, variant not shown              
CK003870 brain/CNS, Human Brain - Cerebellar Cortex Gene FTSJ1, variant not shown         This clone was ignored    
CB108807 Liver Gene FTSJ1, variant not shown         Suspected internal deletion, this clone was ignored    
TI_153990094   Gene FTSJ1, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s-u, .t-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI